McGuireWoods Consulting

This Week in Washington: CMS releases first list of Inflation Rebate Program drugs, initial guidance on Medicare Drug Negotiation Program


Congress

House

Chiropractic Medicare Coverage Modernization Act Reintroduced

On March 14, Reps. Steube (R-FL), Higgins (D-NY), Alford (R-MO) and Larson (D-CT) reintroduced the Chiropractic Medicare Coverage Modernization Act. The legislation would expand Medicare coverage to

This Week in Washington: President releases FY2024 Budget


Congress

House

Prescription Information Modernization Act of 2023 Introduced

On March 9, Reps. Harshbarger (R-TN) and Sherrill (D-NJ) introduced the Prescription Information Modernization Act of 2023. The bipartisan bill would give healthcare professionals the option to choose whether to receive digital or printed versions of prescription information

This Week in Washington: Workforce issues studied, PBMs under more scrutiny


Congress

House

House Oversight and Accountability Committee Chairman Launches Investigation into Pharmacy Benefit Manager Practices

On March 1, House Oversight and Accountability Committee Chairman James Comer (R-KY) announced that he is launching an investigation to analyze whether pharmacy benefit managers’ (PBM) tactics are harming

This Week in Washington: CBO 2023 Budget Report is released


Congress

House

House Not in Session

CBO Releases Presentation of its 2023 Budget and Economic Outlook Report

On Feb. 16, the Congressional Budget Office (CBO) released a presentation showcasing the results it published in its 2023 Budget and Economic Outlook report. The report highlights CBO’s

This Week in Washington: President Biden delivers State of the Union Address, House votes to end CDC COVID-19 Foreign Air Traveler Vaccine Mandate

Congress

House

House Votes to Terminate CDC COVID-19 Vaccine Mandate for Foreign Travelers

On Feb. 8, the U.S. House of Representatives passed H.R. 185, which would end the Centers for Disease Control

This Week in Washington: President Biden announces ending date of COVID-19 PHE, House begins investigations into COVID-19 origins; State of the Union scheduled for Feb. 7

Congress

House

House Energy and Commerce Committee Begins Investigation into COVID-19 Origin

On Feb. 2, Reps. Rodgers (R-WA), Griffith (R-VA) and Guthrie (R-KY) began the House Energy and Commerce

This Week in Washington: Fighting over how to proceed on the debt limit; Congress still finalizing committee assignments


Congress

House

Reps. Lee, DeGette, Pressley and Schakowsky Introduce the Ensuring Equal Access to Abortion Coverage in Health Insurance Act

On Jan. 26, Reps. Lee (D-CA), DeGette (D-CO), Pressley (D-MA) and Schakowsky (D-IL) introduced the Ensuring Equal

This Week in Washington: House and Senate not in session, U.S. reaches debt-ceiling limit



Congress

House

Rep. Frank Pallone Questions FDA and NIH Over Federally Funded Clinical Trial Reporting Compliance

On Jan. 19, Rep. Frank Pallone (D-NJ) sent a letter to the Food and Drug Administration (FDA) and the National Institutes of Health (NIH), raising